The advantages of Mevion Medical Systems’ high-quality and cost-effective proton therapy technology for treating cancer are coming to the Netherlands. Zuidoost Nederland Protonen Therapie Centrum, BV (ZON-PTC) will install a MEVION S250i Proton Therapy System with HYPERSCAN pencil-beam scanning and Mevion’s proprietary Adaptive Aperture technology. The system delivers high-quality adaptive intensity modulated proton therapy (IMPT) treatments with precision and robustness, as described in a company press release.
Located on the Brightlands Maastricht Health Campus, ZON-PTC will, for the first time, make proton therapy available to patients in the southeast region of the Netherlands. Construction of the ZON-PTC facility will begin this year and the first cancer patients will be treated in 2018. The center will be affiliated with MAASTRO clinic and Maastricht University Medical Center with the aim of treating 400 cancer patients per year. Mevion was selected as the preferred vendor after a stringent tender process, says the company.
“Mevion’s compact proton therapy system will give us the ability to treat patients with the latest IMPT technology, including unparalleled treatment speed to minimize motion uncertainties and the sharpest penumbra, without the need for manual apertures and adjustments, while still being the most cost-effective proton solution,” said Geert Bosmans, project director and medical physicist of ZON-PTC. “Additionally, the system will have state-of-the-art 3D radiographic imaging to position the patient, and Mevion’s solutions offer the possibility, if needed, to expand easily in the future.”
Maria Jacobs, CEO of ZON-PTC and MAASTRO clinic said, “Thanks to Mevion’s small footprint, we can simply install the Mevion system in the space of one and a half existing conventional radiation bunkers. Mevion’s proven clinical results, small size and cost-effectiveness make it the gold standard for proton therapy systems.”
The MEVION S250i Proton Therapy System with HYPERSCAN pencil-beam scanning technology that will be installed at ZON-PTC operates at unmatched speeds. It can volumetrically scan a typical lung tumor in less than two seconds – eliminating many of the challenges that slower pencil beam scanning solutions encounter. Additionally, Mevion’s Adaptive Aperture technology includes a low-profile micro-multileaf collimator (mMLC) system designed specifically for pencil beam scanning that is capable of delivering the sharpest penumbra physically achievable with protons without the need for manual apertures and adjustments.
Proton therapy provides targeted treatment to cancer tumors and causes less damage to surrounding healthy tissue than traditional photon radiation. As the world’s smallest proton therapy system, the MEVION S250 Series is less than half the size of any other compact system and uses as little as 30% of the energy used by any other compact system, resulting in significantly lower capital, staffing and operating costs. There are currently six centers with operational Mevion proton therapy systems worldwide.Back To Top
Mevion to bring Hyperscan pencil-beam scanning proton therapy to the Netherlands. Appl Rad Oncol.